Abstract:Since the report of "DNA untwisting" activity in 1972, ~50 years of research has revealed seven topoisomerases in humans (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α, TOP3β and Spo11). These conserved regulators of DNA topology catalyze controlled breakage to the DNA backbone to relieve the torsional stress that accumulates during essential DNA transactions including DNA replication, transcription, and DNA repair. Each topoisomerase-catalyzed reaction involves the formation of a topoisomerase cleavage complex (TOPcc), a covalent protein-DNA reaction intermediate formed between the DNA phosphodiester backbone and a topoisomerase catalytic tyrosine residue. A variety of perturbations to topoisomerase reaction cycles can trigger failure of the enzyme to re-ligate the broken DNA strand(s), thereby generating topoisomerase DNA-protein crosslinks (TOP-DPC). TOP-DPCs pose unique threats to genomic integrity. These complex lesions are comprised of structurally diverse protein components covalently linked to genomic DNA, which are bulky DNA adducts that can directly impact progression of the transcription and DNA replication apparatus. A variety of genome maintenance pathways have evolved to recognize and resolve TOP-DPCs. Eukaryotic cells harbor tyrosyl DNA phosphodiesterases (TDPs) that directly reverse 3′-phosphotyrosyl (TDP1) and 5′-phoshotyrosyl (TDP2) protein-DNA linkages. The broad specificity Mre11-Rad50-Nbs1 and APE2 nucleases are also critical for mitigating topoisomerase-generated DNA damage. These DNA-protein crosslink metabolizing enzymes are further enabled by proteolytic degradation, with the proteasome, Spartan, GCNA, Ddi2, and FAM111A proteases implicated thus far. Strategies to target, unfold, and degrade the protein component of TOP-DPCs have evolved as well. Here we survey mechanisms for addressing Topoisomerase 1 (TOP1) and Topoisomerase 2 (TOP2) DPCs, highlighting systems for which molecular structure information has illuminated function of these critical DNA damage response pathways.

Human mitochondrial topoisomerase I

Identification and Characterization of Mouse MTO1 Gene Related to Mitochondrial Trna Modification.

Biochemical analysis of the endoribonuclease activity of the human mitochondrial topoisomerase 1

Human topoisomerases and their roles in genome stability and organization

Cloning and Characterization of Mouse Mterf Encoding a Mitochondrial Transcriptional Termination Factor.

Tissue-specific Expression Atlas of Murine Mitochondrial Trnas

From the TOP: Formation, Recognition and Resolution of Topoisomerase DNA Protein Crosslinks

Biochemical characterization of the meiosis-essential yet evolutionarily divergent topoisomerase VIB-like protein MTOPVIB from Arabidopsis thaliana

Mycobacterial Topoisomerase I Energetically Suffers From C-Terminal Deletions

DNA wrapping and bending by a mitochondrial high mobility group-like transcriptional activator protein.

Isolation of Cdna Clones Encoding the Β Isozyme of Human DNA Topoisomerase II and Localisation of the Gene to Chromosome 3P24

A Model for the Mechanism of Human Topoisomerase I

Human Topoisomerase IIIα is a Single-stranded DNA Decatenase That is Stimulated by BLM and RMI1*

Cloning and characterization of the 5'-flanking region of the human topoisomerase II alpha gene.

A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of TOP1MT

Activation of the cGAS-STING innate immune response in cells with deficient mitochondrial topoisomerase TOP1MT

Human Topoisomerase IIα Promotes Chromatin Condensation Via a Phase Transition

Crystal structure of the N-terminal region of human Topoisomerase IIβ binding protein 1.

Epigenetic control of Topoisomerase 1 activity presents a cancer vulnerability

Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues

Type II topoisomerases shape multi-scale 3D chromatin folding in regions of positive supercoils